Canadian Tech Company B-Temia Enters Into a $6.9M USD US Army / Lockheed Martin Agreement
B-Temia and Lockheed Martin Team Up to Optimize ONYX™ Exoskeleton
QUÉBEC CITY, Nov. 29, 2018 (GLOBE NEWSWIRE) -- B-Temia, a Canadian robotics tech company and leader in the human mobility market, announced its engagement in a major agreement with U.S. Army Natick Soldier Research, Development and Engineering Center (NSRDEC) with its partner Lockheed Martin (NYSE: LMT), appointed as the prime contractor. At a total value of $6.9M USD, the agreement is for the optimization of the of the ONYXTM exoskeleton, the military version of the B-Temia’s DermoskeletonTM technology, for field trials with military operators. ONYXTM is a brand owned by Lockheed Martin under the B-Temia Enabled
“Our involvement in this major agreement is the result of 2 years of successful teamwork with our defence & security partner Lockheed Martin and our special advisor Ms. Rita Vazquez-Torres (New Stone Soup Inc.). This work is another key event in our growth phase and provides us the ability to significantly increase our technological edge with our DermoskeletonTM technology. B-Temia is now expanding, not only around the world, but also in the military market”, stated Mr. Stephane Bedard, CEO of B-Temia Inc. “This NSRDEC / Lockheed Martin agreement is another acknowledgement from the market on the value of our DermoskeletonTM. We are proud and thrilled to materialize our vision of protecting the biomechanical health of military personnel”, added Mr. Bedard.
ONYX is a powered, lower-body exoskeleton with artificial intelligence (AI) technology that augments human strength and endurance. ONYX counteracts overstress on the lower back and legs. Using electro-mechanical knee actuators, a suite of sensors, and an AI computer, ONYX learns user movements and delivers the right torque at the right time to assist with walking up steep inclines, lifting or dragging heavy loads.
“Innovative human/machine technologies like ONYX can improve human performance, decrease injury and reduce fatigue to help soldiers accomplish physically demanding tasks,” said Keith Maxwell, exoskeleton technologies program manager at Lockheed Martin’s Missiles and Fire Control division. “This award brings us one step closer to equipping future forces with advanced exoskeleton capabilities.”
“We are very pleased to see Quebec-based B-Temia Inc. team up with Lockheed Martin to optimize the ONYX exoskeleton for the US Army. Innovation in robotics is a key initiative for Lockheed Martin and it is great to see a Canadian small-medium enterprise play such an important contributing role in providing solutions,” said Charles Bouchard, Chief Executive of Lockheed Martin Canada.
Founded in 2010, B-Temia Inc. is an innovative Canadian robotics technology company that develops and markets cutting-edge products for the growing market of human augmentation systems. B-Temia operates through two wholly-owned subsidiaries, B-Temia Inc. and B-Temia USA Inc., in the medical, industrial and military fields. B-Temia owns a patented technology called Dermoskeleton™ that restores, maintains or enhances the mobility of users. For more information, please visit: www.b-temia.com
About Lockheed Martin
Headquartered in Bethesda, Maryland, Lockheed Martin is a global security and aerospace company that employs approximately 100,000 people worldwide and is principally engaged in the research, design, development, manufacture, integration and sustainment of advanced technology systems, products and services. This year the company received three Edison Awards for ground-breaking innovations in autonomy, satellite technology and directed energy. For more information, please visit: www.lockheedmartin.com
About New Stone Soup
NSS VT LLC is a cross-government technology strategy consulting firm, specializing in networking across government cultures, and creating solid partnerships between government agencies, industry and academia. We specialize in strategic analysis of goals and objectives, and designing innovative teaming concepts to explore and ultimately transition disruptive technologies to the Military, Homeland Security, Public Safety and Commercial market. NSS has been operating for two years, with over 25 years of combined Military, Homeland Security and Public Safety Science and technology experience. For more information, please visit: http://newstonesoupvt.com/
Information – B-Temia
|B-TEMIA Inc.||Pamela Borges|
|4780, St-Félix Street, Suite 105||VP Market Access & External Affairs|
|St-Augustin (Québec) G3A 2J9||Phone: (416) 520-5270|
|www.b-temia.com | www.keeogo.com||E-mail: firstname.lastname@example.org|
|Phone: (418) 653-1010|
Information – Lockheed Martin
|5600 Sand Lake Road|
|Orlando, FL 32819|
|Phone: (407) 619-8676|
Two photos accompanying this announcement are available at:
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Følg saker fra GlobeNewswire
Registrer deg med din epostadresse under for å få de nyeste sakene fra GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra GlobeNewswire
Atom Power Introduces First Ever Digital Circuit Breaker21.5.2019 15:00:00 CEST | Pressemelding
New technology certified for widespread commercial use, bringing power distribution to the digital age for the first time CHARLOTTE, N.C., May 21, 2019 (GLOBE NEWSWIRE) -- Atom Power, inventor of the world’s first and only digital circuit breaker, today announced its technology is listed by Underwriters Laboratories (UL), the governing standard for consumer safety. This is the first time in the history of commercial power distribution that a digital solid-state circuit breaker has been listed by UL. Circuit breaker technology hasn’t fundamentally changed in more than 140 years. In that time, everything else has — from telegraphs and carriages to smartphones and electric vehicles. Despite massive innovation in renewables, batteries and vehicles, our analog infrastructure hits a series of bottlenecks when these power sources meet at a single point, like a physical structure. “Today, power is plentiful — renewable costs are falling, many structures have generators and batteries store more
Abeona Therapeutics Announces FDA Clearance of Investigational New Drug Application for ABO-202 Gene Therapy in CLN1 Disease21.5.2019 14:00:00 CEST | Pressemelding
NEW YORK and CLEVELAND, May 21, 2019 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in gene and cell therapy, today announced that the Company is cleared to begin a Phase 1/2 clinical trial evaluating its novel, one-time gene therapy ABO-202 for the treatment of CLN1 disease, following acceptance of its Investigational New Drug (IND) application by the U.S. Food and Drug Administration (FDA). ABO-202 is designed to deliver a functional copy of the PPT1 gene to cells of the central nervous system and peripheral organs using a combined intravenous and intrathecal delivery via the AAV9 vector. The Company will provide guidance on the timing of the clinical trial later this year. “This significant step brings hope to people impacted by this devastating disease and was achieved in partnership with Dr. Steven Gray and Taylor’s Tale,” said Timothy J. Miller, Ph.D., Co-Founder, President & Chief Scientific Officer. “We are very encouraged that ABO-202 wa
Invivoscribe Expanding Clinical Laboratory Network Space and Testing Capabilities in San Diego, Germany, Japan, and China. Offering Comprehensive Standardized Testing for All Hematologic Malignancies21.5.2019 12:00:00 CEST | Pressemelding
SAN DIEGO, May 21, 2019 (GLOBE NEWSWIRE) -- Invivoscribe, Inc., a vertically integrated global company focused on Improving Lives with Precision Diagnostics ®, today announces expansion of space and testing capabilities in their international network of accredited LabPMM® clinical laboratories. Additions to the test menu will include morphology, IHC, flow cytometry, as well as the latest multiparameter flow- (MPF), and NGS-based minimal residual disease (MRD) testing of primary specimens. These new services will further support rapid patient diagnosis, study subject enrollment, and study subject stratifications. They will be available by end of this year in San Diego followed by the laboratories in Japan, Germany and China. “Our comprehensive test menu will eliminate the need for partners to split primary specimens, dramatically decreasing turnaround times and accelerating receipt of comprehensive test reports. This is especially important for partners performing international clinical
Canadian Natural Resources Limited Announces Normal Course Issuer Bid21.5.2019 11:00:00 CEST | Pressemelding
CALGARY, Alberta, May 21, 2019 (GLOBE NEWSWIRE) -- Canadian Natural Resources Limited ("Canadian Natural") announced today that the Toronto Stock Exchange has accepted notice filed by Canadian Natural of its intention to make a Normal Course Issuer Bid (“NCIB”) through the facilities of the Toronto Stock Exchange or other alternative Canadian trading systems. Purchases may also be made through the facilities of the New York Stock Exchange. The notice provides that Canadian Natural may, during the 12 month period commencing May 23, 2019 and ending May 22, 2020, purchase for cancellation up to 59,729,706 common shares, being 5% of the 1,194,594,136 issued and outstanding common shares as at May 10, 2019. Canadian Natural will not acquire more than 25% of the average daily trading volume of its common shares during a trading day, being 975,709 common shares subject to certain prescribed exceptions. The price which Canadian Natural will pay for any such shares will be the market price at t
Telia Norway signs partner agreement with IMImobile for Enterprise cPaaS offering21.5.2019 09:00:00 CEST | Pressemelding
Scandinavian telecommunications provider to resell IMImobile’s cPaaS offering, IMIconnect, to enterprise customers LONDON, May 21, 2019 (GLOBE NEWSWIRE) -- IMImobile, a global communications software provider, has signed a partner agreement with Telia Norway, with an option to extend to the wider Telia Company – the leading telecom operator in the Nordic/Baltics. The partner agreement will enable Telia to resell IMImobile’s cloud products, including its enterprise cPaaS (Communications Platform as a Service) offering, IMIconnect, to its enterprise customers. IMIconnect enables businesses to rapidly launch and orchestrate two-way, trigger-based customer communications across 10+ channels. Driven by the changes in person to person communications, consumers now expect interactions with businesses to be personalised, relevant, contextual, interactive and conducted in real time. IMImobile is helping Telia to keep pace with changing consumer expectations and offer innovative communications s
GridGain Joins Cloud Native Computing Foundation21.5.2019 09:00:00 CEST | Pressemelding
Increasingly Deployed in the Cloud, GridGain Looks to Contribute to Growing Body of Cloud Native Best Practices FOSTER CITY, Calif., May 21, 2019 (GLOBE NEWSWIRE) -- GridGain® Systems, provider of enterprise-grade in-memory computing solutions based on Apache® Ignite™, today announced it has joined the Cloud Native Computing Foundation® (CNCF®) and The Linux Foundation. GridGain is demonstrating its support for the CNCF with a Silver Membership and participating in the foundation’s programs and guidance related to supporting cloud native applications. CNCF is an open source software foundation dedicated to making cloud native computing universal and sustainable. CNCF has over 400 members including the world’s largest public cloud and enterprise software companies as well as dozens of innovative startups. Cloud-native computing uses an open source software stack to deploy applications as microservices, packaging each part into its own container, and dynamically orchestrating those conta